Article Versions Notes

Ma Y, Schulz B, Trakooljul N, Al Ammar M, Sekora A, Sender S, Hadlich F, Zechner D, Weiss FU, Lerch MM, et al. Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers. 2022; 14(18):4467. https://doi.org/10.3390/cancers14184467

Ma, Yixuan, Benjamin Schulz, Nares Trakooljul, Moosheer Al Ammar, Anett Sekora, Sina Sender, Frieder Hadlich, Dietmar Zechner, Frank Ulrich Weiss, Markus M. Lerch, and et al. 2022. "Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines" Cancers 14, no. 18: 4467. https://doi.org/10.3390/cancers14184467

Ma, Y., Schulz, B., Trakooljul, N., Al Ammar, M., Sekora, A., Sender, S., Hadlich, F., Zechner, D., Weiss, F. U., Lerch, M. M., Jaster, R., Junghanss, C., & Murua Escobar, H. (2022). Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers, 14(18), 4467. https://doi.org/10.3390/cancers14184467